Nanobiotix (NBTX) Receivables - Net (2019 - 2025)

Nanobiotix's Receivables - Net history runs 6 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• On a quarterly basis, Receivables - Net fell 21.84% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 21.84% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 24.72% from the prior year.
• Receivables - Net climbed to $2.5 million in Q4 2025 per NBTX's latest filing, from $2.1 million in the prior quarter.
• Across five years, Receivables - Net topped out at $3.4 million in Q2 2024 and bottomed at $103045.0 in Q4 2022.
• The 4-year median for Receivables - Net is $1.6 million (2023), against an average of $1.7 million.
• Across the five-year window, Receivables - Net surged 844.95% in 2023 and plunged 38.13% in 2025, its largest moves.
• Year by year, Receivables - Net stood at $103045.0 in 2022, then jumped by 844.95% to $973725.6 in 2023, then jumped by 226.7% to $3.2 million in 2024, then slipped by 21.84% to $2.5 million in 2025.
• Per Business Quant, the three latest NBTX Receivables - Net figures stand at $2.5 million (Q4 2025), $2.1 million (Q2 2025), and $3.2 million (Q4 2024).